“…We decided to analyse these markers as they belong to three different marker groups that may be related to cancer and/or to inflammatory diseases. p27, Skp2, Cox2, CycD1 and Ki67 are considered as tumour and/or proliferation markers (Huang et al, 2003;Siggelkow et al, 2004;Adjei, 2005;Vig-Varga et al, 2006;Garg et al, 2008;Park et al, 2008;Chang et al, 2009;Meeran et al, 2009;Mukhopadhyay et al, 2009), ImAnOx and carbonyls are oxidative markers (Nyström, 2005;Bahar et al, 2007) and MMP-9, -3 and -2 are MMPs that are expressed in various pathological processes such as inflammation and cancer and also in response to infections (Korpos et al, 2009;Oikonomidi et al, 2009;Vanlaere and Libert, 2009). Enhanced oxidative stress characterises both inflammation and cancer; all other markers analysed were also shown previously to be associated with inflammation, as well as with oxidative stress, presumably mediated through the activation of NF-kB (Huang et al, 2003;Vig-Varga et al, 2006;Park et al, 2008;Gonda et al, 2009;Karalis et al, 2009;Ku et al, 2009;Perricone et al, 2009;Víctor et al, 2009).…”